MENU
INCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Incyte (INCY) Ownership - Who owns Incyte?
Incyte focuses on the discovery and development of small-molecule drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.02B
P/E Ratio
336.30
Total Cash
2.41B
Projected Growth
0.12
Total Debt
43.12M
Revenue
4.41B
Risk (Beta)
0.85
Dividend Yield
N/A
Total Cash/Share
12.44
Total Debt/Equity
N/A
Revenue/Share
21.71 USD as % of share price
Fundamentals
INCY
Capitalization
13B
P/E Ratio
336.30
Risk (Beta)
0.85
Dividend Yield
N/A
Total Cash
2.41B
Total Cash/Share
12.44
Total Debt
43.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.12
Revenue/Share (as % of the share price)
21.71%
Revenue
4.41B
ROE
N/A
Book Value
3.67B
P/B Ratio
3.55
Cash Flow
N/A
Earnings
0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
193K
Current Ratio
2.04
Current Revenue Per Employee
402330.16
Dividends Per Share - Security
N/A
EBITDA
407M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.05
Revenue To Assets
0.33
Shares Held By Institutions
27.6B
Shares Outstanding - Current
194M
Total Liabilities
2.08B
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.621
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com